Sofinicline (abt-894 ) for attention-deficit/hyperactivity...

Details Sofinicline (abt-894 ) for attention-deficit/hyperactivity... Sofinicline (abt-894 ) for attention-deficit/hyperactivity...

A - Human Necessities

61

K

A61K 31/4439 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2725470

3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3,6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.

L'invention concerne du 3-(5, 6-dichloro-pyridin-3-yl)-IS,5S-3,6-diazabicyclo[3.2.0]heptane (SOFINICLINE, ABT-894) et des sels de celui-ci qui sont des composés agonistes de récepteur de nicotine efficaces qui ont démontré un effet pharmacologique pour des symptômes associés à un trouble de déficit de l'attention/hyperactivité.

Affiliated with

Also associated with

Rating

Sofinicline (abt-894 ) for attention-deficit/hyperactivity... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sofinicline (abt-894 ) for attention-deficit/hyperactivity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sofinicline (abt-894 ) for attention-deficit/hyperactivity... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1903075